These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 28662514)
41. Emodin Inhibits ATP-Induced Proliferation and Migration by Suppressing P2Y Receptors in Human Lung Adenocarcinoma Cells. Wang X; Li L; Guan R; Zhu D; Song N; Shen L Cell Physiol Biochem; 2017; 44(4):1337-1351. PubMed ID: 29183030 [TBL] [Abstract][Full Text] [Related]
42. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476 [TBL] [Abstract][Full Text] [Related]
43. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition. Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767 [TBL] [Abstract][Full Text] [Related]
44. MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer. Lai J; Yang H; Zhu Y; Ruan M; Huang Y; Zhang Q BMC Cancer; 2019 Jun; 19(1):602. PubMed ID: 31215481 [TBL] [Abstract][Full Text] [Related]
45. Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma. Dai X; Ahn KS; Wang LZ; Kim C; Deivasigamni A; Arfuso F; Um JY; Kumar AP; Chang YC; Kumar D; Kundu GC; Magae J; Goh BC; Hui KM; Sethi G Mol Cancer Ther; 2016 Dec; 15(12):2966-2976. PubMed ID: 27765853 [TBL] [Abstract][Full Text] [Related]
46. Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor β signaling in HCT116 colon cancer cells. Li J; Liu H; Yu J; Yu H Mol Med Rep; 2015 Jul; 12(1):192-8. PubMed ID: 25684678 [TBL] [Abstract][Full Text] [Related]
47. Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells. Choupani J; Alivand MR; M Derakhshan S; Zaeifizadeh M; S Khaniani M J Cell Physiol; 2019 Jun; 234(6):9093-9104. PubMed ID: 30317622 [TBL] [Abstract][Full Text] [Related]
48. Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT. Li R; Wu C; Liang H; Zhao Y; Lin C; Zhang X; Ye C Int J Oncol; 2018 Oct; 53(4):1763-1773. PubMed ID: 30066890 [TBL] [Abstract][Full Text] [Related]
49. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET. Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910 [TBL] [Abstract][Full Text] [Related]
50. Reciprocal expression of Slug and Snail in human oral cancer cells. Nakamura R; Ishii H; Endo K; Hotta A; Fujii E; Miyazawa K; Saitoh M PLoS One; 2018; 13(7):e0199442. PubMed ID: 29969465 [TBL] [Abstract][Full Text] [Related]
51. The inhibitory effects of deep-sea water on doxorubicin‑induced epithelial-mesenchymal transition. Chun SY; Kim S; Nam KS Oncol Rep; 2017 Aug; 38(2):1163-1171. PubMed ID: 28627650 [TBL] [Abstract][Full Text] [Related]
52. miR-760 mediates chemoresistance through inhibition of epithelial mesenchymal transition in breast cancer cells. Hu SH; Wang CH; Huang ZJ; Liu F; Xu CW; Li XL; Chen GQ Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):5002-5008. PubMed ID: 27981531 [TBL] [Abstract][Full Text] [Related]
53. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma. Deng G; Zeng S; Ma J; Zhang Y; Qu Y; Han Y; Yin L; Cai C; Guo C; Shen H Sci Rep; 2017 Jan; 7():41616. PubMed ID: 28134289 [TBL] [Abstract][Full Text] [Related]
54. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition. Sha J; Bai Y; Ngo HX; Okui T; Kanno T Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208465 [TBL] [Abstract][Full Text] [Related]
55. Increased chemoresistance via Snail-Raf kinase inhibitor protein signaling in colorectal cancer in response to a nicotine derivative. Lee TY; Liu CL; Chang YC; Nieh S; Lin YS; Jao SW; Chen SF; Liu TY Oncotarget; 2016 Apr; 7(17):23512-20. PubMed ID: 26992205 [TBL] [Abstract][Full Text] [Related]
56. [Role of SPHK1 regulates multi-drug resistance of small cell lung cancer and its clinical significance]. Yang L; Hu H; Deng Y; Bai Y Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):769-77. PubMed ID: 25404266 [TBL] [Abstract][Full Text] [Related]
57. Silencing of periostin inhibits nicotine-mediated tumor cell growth and epithelial-mesenchymal transition in lung cancer cells. Wu SQ; Lv YE; Lin BH; Luo LM; Lv SL; Bi AH; Jia YS Mol Med Rep; 2013 Mar; 7(3):875-80. PubMed ID: 23314871 [TBL] [Abstract][Full Text] [Related]
58. Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination. Jeon YK; Kim CK; Hwang KR; Park HY; Koh J; Chung DH; Lee CW; Ha GH Cell Death Differ; 2017 Mar; 24(3):469-480. PubMed ID: 28009353 [TBL] [Abstract][Full Text] [Related]
59. Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis. Xue YN; Yu BB; Liu YN; Guo R; Li JL; Zhang LC; Su J; Sun LK; Li Y Prostate; 2019 May; 79(6):647-656. PubMed ID: 30714183 [TBL] [Abstract][Full Text] [Related]
60. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]